Azetin

Quick links to important sections

Azetin

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azetin

Quick Facts

Property Description
Active Ingredient Azelastine hydrochloride
Form Aqueous solution (Nasal spray, Ophthalmic solution)
Pharmacological Class Second-generation H1-receptor Antihistamine
Common Therapeutic Use Managing symptoms of allergic responses (e.g., rhinitis, conjunctivitis)
Origin Synthetic compound (Phthalazinone derivative)

What Kind of Medicine is Azetin and Its Classification?

Azetin is a pharmaceutical product containing the active ingredient Azelastine hydrochloride, a synthetic compound classified primarily as a selective H1-receptor Antihistamine and a Mast Cell Stabilizer. Azelastine’s H1-receptor antagonism is clinically recognized for providing effective symptomatic relief from allergic triggers.

The medication belongs to the second-generation class of antihistamines. This classification is a key differentiating factor, as Azelastine's structure is engineered for targeted action, which allows it to provide effective relief while minimizing the potential for systemic effects often associated with the older generation. The dual function—blocking histamine and stabilizing mast cells—is a unique feature providing a comprehensive anti-allergic action.


Azelastine's Composition and Primary Forms

Azelastine is a single active ingredient product most frequently formulated as an aqueous solution for direct, topical administration to affected membranes. The primary preparations include the nasal solution (metered-dose spray) and the ophthalmic solution (eye drops).

The topical forms utilize an aqueous vehicle to deliver the Azelastine hydrochloride directly to the nasal or ocular mucosa. This approach ensures that the compound's pharmacological action is concentrated precisely at the local site of the allergic reaction, maximizing the impact of the active substance.


What is Azetin's General Therapeutic Purpose?

The general therapeutic purpose of Azetin is to provide rapid and comprehensive relief by intervening early in the complex biological sequence that constitutes an allergic response. The drug is intended to reduce the severity of allergic manifestations by managing the intense irritation and inflammation often associated with seasonal changes.

Its function centers on neutralizing the effects of histamine and preventing the release of various other inflammatory mediators. This dual-acting mechanism contributes to the drug's overall purpose of managing the symptoms associated with the body's overreaction to allergens. The rapid onset of action is a primary focus in its clinical recognition, ensuring the medicine helps ease discomfort quickly by stabilizing the cells responsible for triggering the allergic reaction.

What side effects are possible with Azetin?

Possible Side Effects and Safety Information

The official safety profile of Azetin (Azelastine hydrochloride) is defined by government regulatory documents, which classify known adverse reactions and outline safety limitations based on clinical data. Adverse reactions are grouped by frequency and the body systems affected, in line with regulatory standards.


Frequency-Classified Adverse Reactions

The most frequently reported adverse reaction is dysgeusia (bitter taste), which is classified as Common and linked to the administration site. Other Common reactions reported include somnolence (drowsiness), headache, nasal discomfort (burning, stinging, or pain), epistaxis (nosebleeds), and fatigue. Very Rare events documented through post-marketing surveillance include severe allergic reactions such as anaphylactoid reaction.


System-Organ Class and Safety Limitations

Adverse reactions are organized by the affected bodily system. Effects on the Nervous System include somnolence and dizziness, while Respiratory effects include sneezing and nasal discomfort. Due to the potential for somnolence, regulatory labeling includes specific safety restrictions: patients are cautioned against engaging in hazardous occupations that require complete mental alertness and motor coordination, such as operating machinery or driving a motor vehicle. Concurrent use with alcohol or other Central Nervous System depressants is restricted due to the potential for additive impairment of performance.


Population-Specific Safety Notes

The regulatory label includes specific considerations for certain populations. Based on animal data, Azelastine may cause fetal harm at high oral doses; caution is advised regarding use during pregnancy. Azelastine is excreted into human milk, and caution is recommended during lactation. Safety and effectiveness have not been established in the youngest pediatric age groups; for instance, the nasal spray is not established for seasonal allergic rhinitis in children under 5 years of age.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation structures the Azetin (Azelastine hydrochloride) overdose profile around potential systemic exposure, primarily following accidental oral ingestion of the liquid solution. Overdosage may lead to severe systemic toxicity, necessitating immediate action.

Documented Overdose Manifestations

Clinical Signs
Increased somnolence and drowsiness
Vomiting and tachycardia (rapid heart rate)

Required Emergency Actions

Regulatory authorities mandate that any suspected overdose requires that patients seek immediate medical attention or contact a Poison Control Center right away. Emergency medical care is required due to the potential for severe Central Nervous System (CNS) effects and systemic toxicity. Children are specifically noted as a population at risk for serious adverse reactions following accidental ingestion.

Management and Monitoring

No specific antidote is known for Azelastine overexposure, according to regulatory statements. Management is classified as symptomatic and supportive treatment, focused on managing the clinical presentation. Procedures such as gastric lavage may be considered for recent oral ingestion. Hospital monitoring and continuous observation for CNS effects are required in cases of significant overexposure.

Therapeutic Uses of Azetin

What Azetin Treats: Main Uses and Benefits

The primary role of Azetin is to provide supportive relief for symptoms related to allergic rhinitis and other inflammatory nasal conditions. It is commonly used to help manage symptoms such as sneezing, a runny, stuffy, or itchy nose, and itchy, watery eyes associated with allergies.


Azetin is generally used to provide symptomatic support for the cluster of symptoms associated with both seasonal (hay fever) and perennial (year-round) allergic rhinitis, as well as allergic conjunctivitis. This may assist in addressing symptoms across key domains: nasal congestion and discharge, frequent sneezing, and ocular itching. In clinical contexts, it is considered relevant for easing symptoms in certain cases of non-allergic rhinitis, such as Vasomotor Rhinitis. The support provided contributes to easing the overall symptom load that can interfere with daily stability.

“The medication's support helps patients cope more steadily with manifestations that may affect routine comfort during periods of heightened symptoms.”

Quick Fact: Relief for Nasal and Ocular Irritation

Condition Category Symptoms Managed Supportive Benefit
Allergic Rhinitis Sneezing, runny nose, nasal congestion, itching Contributes to improved comfort during symptomatic periods
Allergic Conjunctivitis Itchy eyes, watery eyes Assists with managing discomfort during symptomatic phases
Non-Allergic Rhinitis Persistent nasal stuffiness/discharge Offers symptomatic relief for conditions presenting with disruptive manifestations

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility for Azetin Use (Official Regulatory Information)

The primary regulatory exclusion for Azetin is a contraindication for any patient with a confirmed hypersensitivity to azelastine hydrochloride or any product component.

Age-Related Eligibility Rules: The nasal spray is approved for adults and adolescents 12 years and older. Pediatric use is established for children 5 or 6 years of age and older, varying by the specific nasal spray strength. The ophthalmic solution is approved for children 3 years and older. Use is not recommended for groups younger than these specified ages as safety and efficacy have not been established by regulatory authorities.

Condition-Specific Eligibility Rules: The medicine's use is conditional during pregnancy; official labeling advises that the benefit must justify the potential risk to the fetus due to limited human data. For lactation, caution is recommended. While no absolute contraindication exists for organ dysfunction, caution is warranted in patients with severe renal impairment due to the potential for increased systemic exposure. No special restrictions are mandated for the geriatric population.

What should I know about interactions with other medicines?

Azetin Interactions with other medicines and products

Official regulatory documents define the interaction profile of Azetin (Azithromycin) across several distinct categories, primarily focusing on cardiac risk and drug exposure modification. Co-administration is strictly forbidden with Pimozide due to the serious risk of severe QTc prolongation and associated cardiac arrhythmias.

Azetin is documented as an inhibitor of P-glycoprotein (P-gp), a transport protein. This role can increase the systemic exposure of co-administered medicines that are P-gp substrates, such as Colchicine, necessitating careful monitoring of the P-gp substrate's effects. Azetin also has an intrinsic ability to prolong the QTc interval; therefore, use with other QTc-prolonging medicines must be avoided or managed with extreme caution, particularly in individuals with pre-existing cardiac risk factors.

Administration also requires strict procedural constraints related to absorption. Aluminum- or magnesium-containing antacids significantly reduce the absorption and subsequent plasma concentration of Azetin. To prevent this reduction in drug exposure, official labeling requires that Azetin administration must be separated by at least two hours from the administration of these antacids. Close monitoring is also necessary when co-administering with oral anticoagulants, such as Warfarin, due to the documented potential for an enhanced anticoagulant effect.

Mechanism of Action

How Azetin Works: Mechanism of Action

Azetin functions as a multi-target inhibitor that modulates several critical cell signaling pathways, resulting in suppressed cell proliferation and decreased inflammatory signaling.


Modulating Core Cell Growth and Survival Signals

This domain describes Azetin’s action as an inhibitor of key kinases, including EGFR, STAT3, and the PI3K/AKT/mTOR cascade. By blocking the activity of these signaling proteins, Azetin suppresses the cellular signal for proliferation and induces programmed cell death (apoptosis), limiting cell viability and multiplication in cells where these pathways are highly activated.


Suppressing Tissue Inflammation and Degradation

Azetin engages mechanisms that suppress inflammatory signaling by inhibiting the NF-kappaB and MAPK pathways. This action also extends to the inhibition of MMP9 expression and activity, leading to the physiological effect of reduced inflammatory cytokine release and suppressed MMP9-mediated matrix degradation.


Interference with Blood Supply Recruitment

This mechanism outlines how Azetin contributes to the suppression of cell growth by affecting the formation of new blood vessels (angiogenesis). By downregulating the production of VEGF through upstream pathway inhibition (like STAT3), the drug helps inhibit neovascularization, thereby restricting the supply of nutrients and oxygen to the tissue.

Dosage and Administration Information

How to use Azetin

Azetin (Azelastine hydrochloride) administration is limited to topical routes. The medicine is used either intranasally via a metered-dose spray for rhinitis indications or as a topical ophthalmic solution for allergic conjunctivitis. This route specificity ensures targeted application to the affected membranes.


Administration Protocol and Frequency

Standard dosing regimens are utilized for the use of this medication. For adults (aged 12 years and older), a common regimen for both the nasal spray and ophthalmic solution is twice daily (b.i.d.) administration, typically scheduled in the morning and evening. An alternative once daily (q.d.) option exists for the 0.15% nasal spray strength when used for seasonal allergic rhinitis.

Treatment duration is structured around clinical context. For seasonal conditions, use is generally linked to the period of allergen exposure; however, the nasal formulation is suitable for long-term use in managing perennial rhinitis.


Preparation and Age-Specific Rules

Proper administration requires adherence to technical procedural steps. The nasal spray device must be primed before the first use by depressing the pump several times until a fine mist is released, ensuring accurate delivery of the metered dose. For the ophthalmic solution, users of soft contact lenses are directed to remove the lenses prior to instillation and wait at least ten minutes before reinserting them.

Age-specific administration rules are also defined, with dosing schedules applicable to pediatric patients. Regimens exist for children as young as 6 months for certain nasal indications and 3 years for ophthalmic use, which applies to specific age groups.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Azetin

Evidence for Azetin in Seasonal Allergic Rhinitis (SAR)

Research on Azetin for Seasonal Allergic Rhinitis (SAR) has primarily relied on short-term, double-blind, placebo-controlled Randomized Controlled Trials (RCTs). Researchers examined how symptoms changed over a defined time interval, typically two to four weeks. The primary outcomes examined included the Total Nasal Symptom Scores (TNSS), a composite score researchers use to assess the intensity of nasal symptoms as reported by patients.

Research describes patterns observed in the studies conducted during periods of increased symptom activity. Some trials described patterns where the average TNSS measurements for groups receiving Azetin differed from the groups receiving placebo across these short follow-up durations. Studies monitored results when Azetin was evaluated in the context of an active comparator.

Evidence for Azetin in Perennial Allergic Rhinitis (PAR)

For Perennial Allergic Rhinitis (PAR), research has also focused on short-term, placebo-controlled RCTs. These studies was studied for their relevance to symptoms that persist year-round. Researchers monitored patient-reported outcomes describing perceived discomfort over periods of about four weeks. Limited data are available for long-term outcomes or how the observed short-term patterns might translate to continuous, year-round management of the condition.

Evidence for Azetin in Chronic Idiopathic Urticaria (CIU) / Chronic Spontaneous Urticaria (CSU)

Research for Chronic Idiopathic Urticaria (CIU) involved Phase III clinical trials. The research examined outcomes capturing phases of heightened symptom activity, such as the severity of itching (pruritus) and the number of wheals (hives), over defined time intervals. The follow-up durations were limited to a few weeks. Consequently, long-term outcomes are not fully established, and there is a significant lack of evidence for the use of Azetin for maintenance or long-term disease control.

What is Still Uncertain About Azetin

The primary limitations stem from the follow-up durations being limited across most indications. Data are still emerging regarding the long-term profile for chronic use. The research provides context but not individual predictions about personal outcomes. Additionally, comparative evidence is lacking to definitively position Azetin against every existing treatment option in head-to-head trials across all key patient subgroups.

Key Studies & References Azela-something for Perennial Allergic Rhinitis: Data on Symptom Control and Quality of Life

Frequently Asked Questions (FAQ)

Common questions about Azetin (FAQ)


Q: How quickly does Azetin start working after you begin taking it?

A: Official information regarding Azetin (azelastine hydrochloride) describes a rapid onset of action. For the nasal spray, this rapid action is often reported to occur within minutes following administration. The rapid onset of action is a feature described in the clinical information.


Q: What is the typical time frame to see the expected effects of Azetin?

A: Clinical studies for the conditions Azetin treats often focus on symptom changes over relatively short time frames. For example, researchers typically examine changes in symptoms over periods of two to four weeks in clinical trials. Questions about specific treatment duration are best discussed with a healthcare professional.


Q: Can Azetin be taken with common supplements like multivitamins or fish oil?

A: According to the official product information, patients are generally described as continuing a normal diet unless otherwise directed by a healthcare provider. The labeling does not specifically list common supplements such as multivitamins or fish oil as known interacting substances.


Q: Can Azetin be taken by someone who has diabetes?

A: Official documentation does not list diabetes as a specific contraindication for Azetin use. Like all medicines, the product may have infrequent side effects, such as reported cases of hypertension (high blood pressure) in clinical trials. Reviewing all medical conditions with a healthcare professional is consistent with recommended practice.


Q: Can Azetin be crushed or split if the tablet is too large to swallow?

A: Azetin (azelastine hydrochloride) is not formulated as a tablet meant for swallowing. It is available only as an aqueous nasal spray or an ophthalmic solution (eye drops). The medicine is designed to be administered only by these specific topical routes, which are not tablets.


Q: Are there specific times of day that are better for taking Azetin?

A: The most common official dosing regimen for Azetin involves twice daily administration. This schedule is typically recommended for the morning and the evening to align with a schedule that provides consistent relief, as evaluated in studies.


Q: Are there any common foods or drinks that should be avoided with Azetin?

A: The regulatory documents advise avoiding the concurrent use of alcohol because it may increase the risk of somnolence (drowsiness). There are no common foods or non-alcoholic drinks explicitly listed in the official labeling that must be avoided. Disclosing all substances, including alcohol, to a healthcare professional is consistent with patient safety practices.


Q: Does Azetin affect fertility in men or women?

A: Nonclinical studies conducted in animals, such as rats, showed no reported effects on male or female fertility when given high doses of azelastine. Official product labeling contains no warnings regarding impacts on human fertility.


Q: Is Azetin used for anything other than its main approved use?

A: Official regulatory documents limit the approved uses of Azetin to the specific allergic conditions and age groups listed on the label. The official documentation does not contain information about the use of Azetin for conditions outside of its approved indications.


Q: Is it normal to feel a little tired when first starting Azetin?

A: Regulatory documents classify somnolence (or drowsiness) as a common adverse reaction reported in clinical trials involving the use of the Azetin nasal spray. This effect on the nervous system may cause a feeling of tiredness.


Q: Do I need to change my diet while taking Azetin?

A: Official patient information generally states that patients should continue their normal diet while using Azetin. Specific dietary restrictions are based on individual circumstances and known interactions, and are communicated by a healthcare professional.


Q: Does Azetin interact with over-the-counter pain relievers like ibuprofen?

A: The official product labeling does not explicitly list nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen as medicines that have known interactions with Azetin. However, checking with a healthcare professional about all other medicines being taken is appropriate.


Q: What happens if I forget to take a dose of Azetin?

A: The patient labeling describes using a missed dose as soon as it is remembered. If it is almost time for your next scheduled dose, the labeling describes skipping the missed dose and continuing the regular dosing schedule.


Q: Can people with kidney problems use Azetin?

A: Studies on oral single doses of azelastine have shown that patients with renal insufficiency (moderate to severe kidney problems) may have an increased concentration of the drug in their blood. This finding indicates that caution is generally observed for this population.


Q: Is Azetin safe for someone with a history of liver issues?

A: Official pharmacokinetic studies found that liver impairment did not appear to significantly influence the way Azelastine is processed by the body following oral administration. All medical conditions are appropriate topics for discussion with a doctor.


Q: Are there different versions or brands of Azetin?

A: Azetin is a brand name for the active ingredient azelastine hydrochloride, which is available under multiple brand names internationally. The product is also commonly available as a generic medication.


Q: How long does Azetin stay in the body after the last dose?

A: Following intranasal administration, the elimination of azelastine from the body is relatively slow. The half-life ( t1/2) of the main compound is approximately 25 hours, and the active component has a t1/2 of approximately 57 hours.


Q: Is there any risk of becoming dependent on Azetin?

A: Official product information does not contain any warnings or precautions regarding abuse, dependence, or potential for addiction. Azetin is not listed as a controlled substance.


Q: Can Azetin cause a 'rebound' effect if you stop taking it suddenly?

A: Azetin is not classified as a sympathomimetic drug, which are the type typically associated with causing 'rebound' congestion when use is stopped. The official label does not include warnings about this specific effect.


Q: Does Azetin show up on standard drug tests?

A: Official regulatory documents do not include specific information on the detection of Azetin or its metabolites in standard drug screening panels. This topic is not addressed in the product labeling.


Q: Is Azetin a controlled substance?

A: Azetin (azelastine hydrochloride) is not classified as a controlled substance by the U.S. Drug Enforcement Administration or other corresponding regulatory bodies.


Q: Does Azetin affect blood pressure?

A: In the clinical trials for Azetin, hypertension (high blood pressure) was reported as an adverse reaction by less than 2% of patients. Discussions of existing cardiovascular conditions with a doctor are consistent with medical practice.


Q: Is Azetin known to interact with herbal remedies like St. John's Wort?

A: The official product labeling for Azetin does not specifically list St. John's Wort or other common herbal remedies as known interacting substances. Disclosing all products, including supplements and herbs, to a healthcare professional is consistent with patient safety guidelines.


Q: Are there any specific activities or sports that are discouraged while on Azetin?

A: Due to the common risk of somnolence (drowsiness), official documents caution patients against engaging in hazardous occupations. This caution relates to activities that require complete mental alertness and motor coordination, such as operating heavy machinery.


Q: Does Azetin interact with nicotine products or smoking?

A: Official regulatory documentation does not specify an interaction between Azetin and nicotine products or smoking. Disclosing all substance use, including nicotine, to a healthcare professional is consistent with recommended practice.

How should Azetin be stored and disposed of?

Official Storage and Disposal Requirements

Storage Conditions

Azetin (Azelastine Nasal Spray) must be stored at room temperature and kept away from excess heat and moisture. The medication must remain in its original container, tightly closed, and stored in a location that is out of the sight and reach of children. The product is intended for single-patient use.

Stability and Handling

Each bottle must be primed before initial use and re-primed if unused for three or more days. The regulatory labeling indicates that the correct amount of medication cannot be assured after the designated number of metered sprays (e.g., 200 total sprays) has been used, requiring disposal afterward.

Disposal Instructions

Expired or unused Azetin should be disposed of by following official pharmaceutical waste rules. The preferred method is a drug take-back program or authorized collection site. If a take-back program is unavailable, the product should be mixed with an undesirable substance, placed in a sealed bag, and thrown into the household trash. It must not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azetin found in:

A-Z Index: